BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30968302)

  • 1. Cefepime challenge after piperacillin/tazobactam-induced thrombocytopenia.
    Beaulieu C; Kurczewski L; Yajnik V
    J Thromb Thrombolysis; 2019 Jul; 48(1):167-170. PubMed ID: 30968302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-reactivity between piperacillin-tazobactam and cefoperazone-sulbactam in drug-induced immune thrombocytopenia.
    He X; Huang W; Wan X; Li X; Chang Q; Ding L
    J Int Med Res; 2023 Mar; 51(3):3000605231162434. PubMed ID: 36967671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes following treatment of Enterobacter species pneumonia with piperacillin/tazobactam compared to cefepime or ertapenem.
    Holsen MR; Wardlow LC; Bazan JA; Fussner LA; Coe KE; Elefritz JL
    Int J Antimicrob Agents; 2019 Dec; 54(6):824-828. PubMed ID: 31319191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid-Onset Thrombocytopenia Following Piperacillin-Tazobactam Reexposure.
    Nguyen VD; Tourigny JF; Roy R; Brouillette D
    Pharmacotherapy; 2015 Dec; 35(12):e326-30. PubMed ID: 26684560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Nephrotoxicity of Vancomycin in Combination With Cefepime, Meropenem, or Piperacillin/Tazobactam: A Prospective, Multicenter Study.
    Mullins BP; Kramer CJ; Bartel BJ; Catlin JS; Gilder RE
    Ann Pharmacother; 2018 Jul; 52(7):639-644. PubMed ID: 29442542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of experimental pneumonia in rats caused by a PER-1 extended-spectrum beta-lactamase-producing strain of Pseudomonas aeruginosa.
    Mimoz O; Elhelali N; Léotard S; Jacolot A; Laurent F; Samii K; Petitjean O; Nordmann P
    J Antimicrob Chemother; 1999 Jul; 44(1):91-7. PubMed ID: 10459815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic Target Attainment for Cefepime, Meropenem, and Piperacillin-Tazobactam Using a Pharmacokinetic/Pharmacodynamic-Based Dosing Calculator in Critically Ill Patients.
    Heil EL; Nicolau DP; Farkas A; Roberts JA; Thom KA
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29967022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefepime vs Piperacillin-Tazobactam in Adults Hospitalized With Acute Infection: The ACORN Randomized Clinical Trial.
    Qian ET; Casey JD; Wright A; Wang L; Shotwell MS; Siemann JK; Dear ML; Stollings JL; Lloyd BD; Marvi TK; Seitz KP; Nelson GE; Wright PW; Siew ED; Dennis BM; Wrenn JO; Andereck JW; Han JH; Self WH; Semler MW; Rice TW;
    JAMA; 2023 Oct; 330(16):1557-1567. PubMed ID: 37837651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing antimicrobial stewardship initiatives: Clinical evaluation of cefepime or piperacillin/tazobactam in patients with bloodstream infections secondary to AmpC-producing organisms.
    McKamey L; Venugopalan V; Cherabuddi K; Borgert S; Voils S; Shah K; Klinker KP
    Int J Antimicrob Agents; 2018 Nov; 52(5):719-723. PubMed ID: 30125680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piperacillin/tazobactam-induced sudden severe thrombocytopenia in a patient with a pressure ulcer: a case report.
    Roh S; Hashimoto K; Kiriishi R; Matsubara K; Isozaki Y; Tanaka H; Kuwata T
    J Wound Care; 2024 Jun; 33(Sup6):S25-S30. PubMed ID: 38843043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A targeted likelihood estimation comparing cefepime and piperacillin/tazobactam in critically ill patients with community-acquired pneumonia (CAP).
    Serrano-Mayorga CC; Duque S; Ibáñez-Prada ED; Garcia-Gallo E; Arrieta MPR; Bastidas A; Rodríguez A; Martin-Loeches I; Reyes LF
    Sci Rep; 2024 Jun; 14(1):13392. PubMed ID: 38862579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort Study.
    Hammond DA; Smith MN; Painter JT; Meena NK; Lusardi K
    Pharmacotherapy; 2016 May; 36(5):463-71. PubMed ID: 26952639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefepime plus amikacin versus piperacillin-tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: results of an open, randomized, multicentre trial.
    Sanz MA; López J; Lahuerta JJ; Rovira M; Batlle M; Pérez C; Vázquez L; Julià A; Palau J; Gutiérrez M; Capote FJ; Ramos F; Benlloch L; Larrea L; Jarque I;
    J Antimicrob Chemother; 2002 Jul; 50(1):79-88. PubMed ID: 12096010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid onset severe thrombocytopenia following reexposure to piperacillin-tazobactam: report of two cases and review of the literature.
    Alzahrani M; Alrumaih I; Alhamad F; Abdel Warith A
    Platelets; 2018 Sep; 29(6):628-631. PubMed ID: 29863943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An unusual case of piperacillin-tazobactam-induced fever, eosinophilia, thrombocytopenia and liver damage.
    Lv J; Wu G; Zhang F; Su X
    Eur J Hosp Pharm; 2022 Mar; 29(e1):e91-e94. PubMed ID: 33558219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is high-dose β-lactam therapy associated with excessive drug toxicity in critically ill patients?
    McDonald C; Cotta MO; Little PJ; McWhinney B; Ungerer JP; Lipman J; Roberts JA
    Minerva Anestesiol; 2016 Sep; 82(9):957-65. PubMed ID: 27054905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piperacillin/tazobactam-induced immune-mediated thrombocytopenia in the intensive care unit.
    Boyce K; Brar H; Stabler SN
    J Clin Pharm Ther; 2016 Dec; 41(6):730-732. PubMed ID: 27670947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematologic adverse effects induced by piperacillin-tazobactam: a systematic review of case reports.
    Wang Q; He Z; Wu X; Wei Y; Huang J
    Int J Clin Pharm; 2020 Aug; 42(4):1026-1035. PubMed ID: 32500262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute Kidney Injury in Hematopoietic Cell Transplantation Patients Receiving Vancomycin and Piperacillin/Tazobactam Versus Vancomycin and Cefepime.
    Clemmons AB; Bech CF; Pantin J; Ahmad I
    Biol Blood Marrow Transplant; 2018 Apr; 24(4):820-826. PubMed ID: 29292056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric drug utilization evaluation of cefepime and piperacillin/tazobactam.
    Prasopchoknapaporn P; Boonsathorn S; Techasaensiri C; Chaisavaneeyakorn S; Apiwattanakul N
    Pediatr Int; 2022 Jan; 64(1):e15276. PubMed ID: 36257611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.